---
title: Improve hand dexterity with phygital
nct_id: NCT07475741
phase: NA
status: RECRUITING
sponsor: University of Health Sciences Lahore
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07475741"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07475741"
last_fetched: "2026-05-10T14:04:37.416Z"
source: "Parkinson's Pathways (curated)"
---
# Improve hand dexterity with phygital

**Goal (in five words):** Improve hand dexterity with phygital

**Official Title:** Exergaming With Physical Onjects for Upper Limb Rehabilitation in Parkinson's Disease: Effects on Functional Outcome

**Trial ID:** [NCT07475741](https://clinicaltrials.gov/study/NCT07475741)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University of Health Sciences Lahore
- **Target Enrollment:** 30 participants
- **Start Date:** 2026-02-20
- **Completion Date:** 2026-09
- **Conditions:** Parkinsons Disease (PD)
- **Interventions:** Exergaming, Conventional Physical Therapy
- **Intervention Types:** COMBINATION_PRODUCT, PROCEDURE

## Summary For Families

The goal is to improve upper limb function and everyday hand use in people with early-stage Parkinson's, by comparing an engaging exergaming approach to conventional physical therapy. The exergaming uses interactive games that require manipulating physical objects to train strength, coordination, fine motor control and timing, a form of repetitive, task-specific practice that supports motor learning and neuroplasticity, and it is a rehabilitative approach that complements levodopa/carbidopa rather than replacing or chemically interacting with it. The trial is looking for adults 45 to 85 with Hoehn and Yahr stage I to III PD who can follow commands, have an MMSE of 24 or higher, and are on regular levodopa/carbidopa, while excluding advanced-stage disease, significant cognitive impairment, other neurologic or musculoskeletal hand problems, or use of medicines for systemic illnesses.

## Eligibility

- **Minimum age:** 45 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Early-stage Parkinson's Disease from I-III of Hoehn and Yahr scale
* Cognitinve Assessment MMSE \>= 24 Score
* Able to communicate and understand the commands
* Must be on regular use of Levodopa/carbidopa

Exclusion Criteria:

* Advanced stage IV or V
* Patients with severe cognitive deficits.
* History of suffering from other neurological or musculoskeletal conditions affecting hand use for the exercise
* Not taking any medicine for systemic illness
```

## Locations (1)

- Punjab institute of Neuroscience Lahore, Lahore, Punjab Province, Pakistan _(31.5580, 74.3507)_
  - Prof. Dr. Mohsin Zaheer, FCPS — (CONTACT) — +924299268855 — info@pins.org.pk
  - Hafiz Muddassir Riaz, Ph.D Scholar — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Hafiz Muddassir Riaz, Ph.D Scholar — (CONTACT) — +92345-6627409 — muddassir.riaz@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT07475741*  
*HTML version: https://parkinsonspathways.com/trial/NCT07475741*  
*Source data: https://clinicaltrials.gov/study/NCT07475741*